![]() |
市場調查報告書
商品編碼
1971407
A2牛奶市場-全球產業規模、佔有率、趨勢、機會和預測(按產品類型、銷售管道、地區和競爭格局分類,2021-2031年)A2 Milk Market - Global Industry Size, Share, Trends, Opportunity and Forecast, By Product Type (Powder, Liquid), By Sales Channel (Supermarket/Hypermarket, Convenience Stores, Online, Others), By Region & Competition, 2021-2031F |
||||||
全球 A2 牛奶市場預計將從 2025 年的 42.9 億美元大幅成長至 2031 年的 115.4 億美元,複合年成長率達 17.93%。
A2牛奶與傳統乳製品的差別在於,它只含有A2 BETA-酪蛋白,而非普通牛奶中常見的A1型酪蛋白。這一市場趨勢主要源於消費者對消化健康的日益關注,因為人們普遍認為,A2牛奶中不含A1蛋白,可以緩解對普通乳製品敏感人群的腸胃不適。此外,消費者對天然、加工最少的機能性食品的廣泛需求也進一步推動了這一趨勢,因為注重健康的消費者在尋求基礎營養補充之外的更多營養益處。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 42.9億美元 |
| 市場規模:2031年 | 115.4億美元 |
| 複合年成長率:2026-2031年 | 17.93% |
| 成長最快的細分市場 | 線上 |
| 最大的市場 | 亞太地區 |
儘管消費者需求旺盛,但許多地區基因檢驗牛數量有限,嚴重限制了牛奶供應擴充性。這種短缺導致必須採取嚴格的隔離和檢測程序以確保牛奶純度,從而增加了營運成本、提高了零售價格,並限制了牛奶進入大眾市場。然而,某些地區擁有獨特的供應優勢。例如,根據印度酪農協會的報告,到2024年,印度生產的牛奶中約有90%將是A2牛奶。這項數據歸功於當地廣泛飼養具有這種特定基因特徵的本地牛。
消費者對A2 BETA-酪蛋白消化器官系統益處的認知不斷提高,是推動市場成長的核心動力。隨著越來越多的消費者開始區分A1蛋白(通常與發炎和消化器官系統問題相關)和A2蛋白(被認為對消化器官系統更溫和),成熟市場正呈現出向功能性替代乳製品顯著轉變的趨勢。這一趨勢在近期的業績指標中得到了印證。例如,A2牛奶公司於2024年8月發布的《2024會計年度說明》顯示,美國液態乳製品銷量成長了7.4%,證實了溫和型乳製品正逐漸成為美國消費者的主流選擇。
第二個強勁的驅動力是市場對優質A2蛋白嬰幼兒配方奶粉的需求不斷成長,尤其是在全部區域。父母越來越願意為能夠忠實模擬母乳蛋白質結構的配方奶粉支付更高的價格,儘管面臨經濟挑戰,這個高價值細分市場仍然蓬勃發展。該產業受惠於龐大的加工能力,新萊乳業有限公司於2024年9月發布的2024會計年度年度報告顯示,其總收入將達到16.4億紐西蘭元。此外,該細分市場的強勁勢頭也反映在銷售業績上。 2024年8月,A2奶粉報告稱,其對華嬰幼兒配方奶粉銷量成長了9.5%,儘管競爭激烈,但仍取得了有史以來最高的市場佔有率。
全球A2牛奶市場面臨的主要限制因素是供應難以擴大。這個問題主要源自於某些地區以外缺乏經過基因檢測的牛。與傳統酪農養殖不同,A2牛奶的生產必須使用經基因檢測確認只含有A2 BETA-酪蛋白的乳牛。為了確保完全消除A1蛋白,生產商必須從擠乳到加工包裝全程實施嚴格的隔離通訊協定。這些全面的檢驗和隔離措施會產生顯著的營運成本,最終導致更高的消費者價格,使得A2牛奶的價格無法與傳統牛奶的價格水準相當。
因此,成本效益高的產能擴張舉步維艱,市場被限制在高階細分領域,嚴重阻礙了其對大眾市場的滲透。牛轉型帶來的物流挑戰阻礙了供應的快速成長,而消費者需求主要集中在高階價格區間,難以被廣泛接受為日常必需品。農業利用研究所的數據凸顯了這些限制的嚴重性,指出到2024年,A2乳製品僅佔乳製品市場總量的1.3%。這項數據強調,供應方面的限制以及由此產生的價格結構仍然阻礙著該行業的普及。
全球A2牛奶市場供應結構正因基因組檢測在牛群認證中的廣泛應用而改變。酪農們正擴大利用先進的基因篩檢技術來識別和選擇性培育攜帶A2A2BETA-酪蛋白變異基因的牛,從而有效地加速了從傳統牛群向認證A2牛群的轉型。這種策略方法使酪農能夠有效率地隔離乳源,直接應對擴充性的挑戰,同時確保產品的真實性。這種以基因為重點的策略的成功體現在育種資源上;根據農業利用研究所2024年11月發布的《A2牛奶市場評估報告》,基因供應商名錄中列出的荷斯坦牛中有75%已被檢驗攜帶A2A2BETA-酪蛋白變異基因。
同時,A2蛋白在運動營養和機能飲料的應用也推動了市場擴張,滿足了人們除簡單消化之外的其他健康需求。各公司正在開發強化粉劑和即飲奶昔,將A2BETA-酪蛋白的消化益處與增強免疫力、提升運動表現和促進恢復的功能性成分相結合,尤其適用於活躍的成年人和老年人。進軍高附加價值領域使品牌能夠實現產品線多元化,並獲得更高的定價權。例如,根據A2牛奶公司於2024年8月發布的《2024會計年度財務業績說明》,包括強化功能粉劑在內的「其他營養產品」板塊的銷售額成長了36.7%。
The Global A2 Milk Market is projected to expand significantly, rising from a valuation of USD 4.29 Billion in 2025 to USD 11.54 Billion by 2031, reflecting a compound annual growth rate of 17.93%. A2 milk is distinguished from conventional dairy by its exclusive content of the A2 beta-casein protein type, lacking the A1 variant typically found in regular cow's milk. The market's upward trajectory is primarily fueled by increasing consumer awareness regarding digestive wellness, as the exclusion of the A1 protein is frequently linked to fewer gastrointestinal issues for those sensitive to standard dairy. This momentum is further bolstered by a broader consumer shift toward natural, minimally processed functional foods, as health-oriented individuals seek nutritional advantages that offer more than just basic sustenance.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 4.29 Billion |
| Market Size 2031 | USD 11.54 Billion |
| CAGR 2026-2031 | 17.93% |
| Fastest Growing Segment | Online |
| Largest Market | Asia Pacific |
Despite strong consumer interest, the market encounters substantial obstacles related to supply scalability, stemming from the limited availability of genetically verified herds in many regions. This scarcity necessitates strict segregation and testing procedures to ensure purity, resulting in elevated operational costs and premium retail pricing that restrict mass-market accessibility. However, certain regions possess inherent supply advantages; for example, the Indian Dairy Association reported that in 2024, roughly 90% of milk produced in India was A2 milk, a statistic credited to the prevalence of indigenous cattle breeds that naturally possess this specific genetic characteristic.
Market Driver
Growing consumer recognition of the digestive benefits associated with A2 beta-casein serves as a central engine for market growth. As individuals increasingly differentiate between the A1 protein, which is often connected to inflammation and digestive distress, and the A2 variant, considered gentler on the system, there is a notable shift toward functional dairy alternatives in mature markets. This trend is evident in recent performance metrics; for example, The a2 Milk Company's 'FY24 Results Commentary' from August 2024 highlighted a 7.4% increase in liquid milk sales within the USA, illustrating the expanding mainstream adoption of digestion-friendly dairy among American consumers.
A second powerful driver is the escalating demand for premium A2 protein-based infant formula, particularly throughout the Asia-Pacific sector. Parents are increasingly willing to pay higher prices for formulas that closely replicate the protein structure of human breast milk, sustaining this high-value segment even amidst economic challenges. This sector is underpinned by massive processing capabilities, as demonstrated by Synlait Milk Limited's 'Annual Report 2024' from September 2024, which reported total revenue of NZ$1.64 billion. Furthermore, the segment's strength is reflected in sales figures; The a2 Milk Company reported in August 2024 that sales of their China label infant milk formula rose by 9.5%, securing record market share despite fierce competition.
Market Challenge
A critical limitation for the Global A2 Milk Market is the difficulty in scaling supply, a problem largely attributed to the shortage of genetically verified herds outside specific geographic areas. Unlike standard dairy operations, A2 milk production demands the exclusive use of cows confirmed via genetic testing to carry only the A2 beta-casein variant. To guarantee the total absence of the A1 protein, producers must enforce rigorous segregation protocols spanning from milking to processing and packaging. These comprehensive verification and separation measures generate significant operational expenses, which ultimately lead to higher consumer prices and prevent A2 products from reaching price parity with conventional milk.
Consequently, the inability to cost-effectively scale production confines the market to a premium niche, significantly hindering its ability to penetrate the mass market. The logistical challenges associated with converting herds impede rapid supply growth, ensuring that consumer demand is met primarily at luxury price points rather than as an everyday staple. The severity of these restrictions is highlighted by data from the Agricultural Utilization Research Institute, which noted that in 2024, A2 dairy products accounted for only 1.3% of the overall dairy market. This statistic underscores how supply-side constraints and the resulting pricing structure continue to limit the sector's broader reach.
Market Trends
The supply landscape of the Global A2 Milk Market is being transformed by the widespread integration of genomic testing for herd certification. Dairy producers are increasingly utilizing sophisticated genetic screening technologies to identify and selectively breed cattle that carry the A2A2 beta-casein variant, effectively speeding up the conversion from conventional to certified A2 herds. This strategic approach enables farmers to segregate milk sources efficiently, directly tackling scalability issues while guaranteeing product authenticity. The success of this genetic focus is reflected in breeding resources; the Agricultural Utilization Research Institute's 'A2 Milk Market Assessment' from November 2024 noted that 75% of Holstein sires listed in genetic provider directories were verified as possessing the A2A2 beta-casein variant.
In parallel, the market is expanding through the inclusion of A2 protein in sports nutrition and functional beverages, addressing health requirements that extend beyond simple digestion. Companies are developing fortified powders and ready-to-drink shakes that merge the digestive benefits of A2 beta-casein with functional ingredients designed to support immunity, mobility, and recovery for active adults and aging demographics. Moving into these high-value categories allows brands to diversify their offerings and secure premium margins; for instance, The a2 Milk Company's 'FY24 Results Commentary' from August 2024 reported that revenue from its other nutritional products segment, including fortified functional powders, increased by 36.7%.
Report Scope
In this report, the Global A2 Milk Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global A2 Milk Market.
Global A2 Milk Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: